[T]he company has not set aside one dime for potential damage awards in Vioxx trials through 2007. Which means the only good news to report as far as Merck's legal strategy of a case by case defense of thousands of lawsuits in the years ahead, is that the company's legal team will keep raking in dough while Merck slowly goes under.
An interesting article, although I don't know about Merck "going under," as it has quite a few high-profile drugs in the pipeline that analysts say could be huge earners.
0 comments:
Post a Comment